 
         
         
         Abstract
         
         In this study we have analyzed the mtDNA encoded ATPase 6 and 8 genes (MTATP6 and MTATP8) in two children with Leigh syndrome (LS) and reduced Mg2+ ATPase activity in muscle mitochondria. In patient 1, with a mild and reversible
            phenotype, mutational analysis revealed a heteroplasmic T → C mutation at nt position
            9185 (T9185C) in the MTATP6. The mutation resulted in substitution of a highly conserved leucine to proline at
            codon 220. The proportion of the mutation was > 97 % in the patient's blood and muscle
            and 85 % in blood of his asymptomatic mother. Patient 2, with severe clinical phenotype
            and death at 2 years of age, exhibited a novel heteroplasmic T9191C missense mutation
            in the MTATP6, which converted a highly conserved leucine to a proline at position 222 of the polypeptide.
            The proportion of the mutation was 90 % in fibroblasts and 94 % muscle tissue. This
            mutation was absent in the patient's parents and sister suggesting that the mutation
            was de novo. Our findings expand the spectrum of mutations causing LS and emphasize the role
            of MTATP6 gene mutations in pathogenesis of LS.
         
         
         
            
Key words
         
         
            Leigh syndrome - mtDNA - 
               MTATP6
               - complex V - ATP synthase
          
      
    
   
      
         References
         
         
            - 1 
               Darin N, Oldfors A, Moslemi A R, Holme E, Tulinius M. 
               The incidence of mitochondrial encephalomyopathies in childhood: clinical features
               and morphological, biochemical, and DNA abnormalities. 
               Ann Neurol. 
               2001; 
               49 
               377-383 
               
- 2 
               Leigh D. 
               Subacute necrotizing encephalomyelopathy in an infant. 
               J Neurochem. 
               1951; 
               14 
               216-221 
               
- 3 
               Davis P C, Hoffman Jr J C, Braun I F, Ahmann P, Krawiecki N. 
               MR of Leigh's disease (subacute necrotizing encephalomyelopathy). 
               AJNR Am J Neuroradiol. 
               1987; 
               8 
               71-75 
               
- 4 
               Tulinius M, Moslemi A R, Darin N. et al .
               Leigh syndrome with cytochrome-c oxidase deficiency and a single T insertion nt 5537
               in the mitochondrial tRNATrp gene. 
               Neuropediatrics. 
               2003; 
               34 
               87-91 
               
- 5 
               Santorelli F M, Shanske S, Jain K D, Tick D, Schon E A, DiMauro S. 
               A T → C mutation at nt 8993 of mitochondrial DNA in a child with Leigh syndrome. 
               Neurology. 
               1994; 
               44 
               972-974 
               
- 6 
               Dionisi-Vici C, Seneca S, Zeviani M. et al .
               Fulminant Leigh syndrome and sudden unexpected death in a family with the T9176C mutation
               of the mitochondrial ATPase 6 gene. 
               J Inherit Metab Dis. 
               1998; 
               21 
               2-8 
               
- 7 
               Moslemi A R, Tulinius M, Darin N, Aman P, Holme E, Oldfors A. 
               SURF1 gene mutations in three cases with Leigh syndrome and cytochrome c oxidase deficiency. 
               Neurology. 
               2003; 
               61 
               991-993 
               
- 8 
               Manfredi G, Fu J, Ojaimi J. et al .
               Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded
               gene, to the nucleus. 
               Nat Genet. 
               2002; 
               30 
               394-399 
               
- 9 
               Tulinius M H, Holme E, Kristiansson B, Larsson N G, Oldfors A. 
               Mitochondrial encephalomyopathies in childhood. I. Biochemical and morphologic investigations. 
               J Pediatr. 
               1991; 
               119 
               242-250 
               
- 10 
               Oldfors A, Moslemi A R, Fyhr I M, Holme E, Larsson N G, Lindberg C. 
               Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. 
               J Neuropathol Exp Neurol. 
               1995; 
               54 
               581-587 
               
- 11 
               Moslemi A R, Melberg A, Holme E, Oldfors A. 
               Autosomal dominant progressive external ophthalmoplegia: distribution of multiple
               mitochondrial DNA deletions. 
               Neurology. 
               1999; 
               53 
               79-84 
               
- 12 
               Andrews R M, Kubacka I, Chinnery P F, Lightowlers R N, Turnbull D M, Howell N. 
               Reanalysis and revision of the Cambridge reference sequence for human mitochondrial
               DNA. 
               Nat Genet. 
               1999; 
               23 
               147 
               
- 13 
               Moslemi A R, Tulinius M, Holme E, Oldfors A. 
               Threshold expression of the tRNA(Lys) A8344G mutation in single muscle fibres. 
               Neuromuscul Disord. 
               1998; 
               8 
               345-349 
               
- 14 
               Thyagarajan D, Shanske S, Vazquez-Memije M, De Vivo D, DiMauro S. 
               A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. 
               Ann Neurol. 
               1995; 
               38 
               468-472 
               
- 15 
               Holt I J, Harding A E, Petty R K, Morgan-Hughes J A. 
               A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. 
               Am J Hum Genet. 
               1990; 
               46 
               428-433 
               
- 16 
               Lamminen T, Majander A, Juvonen V. et al .
               A mitochondrial mutation at nt 9101 in the ATP synthase 6 gene associated with deficient
               oxidative phosphorylation in a family with Leber hereditary optic neuroretinopathy. 
               Am J Hum Genet. 
               1995; 
               56 
               1238-1240 
               
- 17 
               de Vries D D, van Engelen B G, Gabreels F J, Ruitenbeek W, van Oost B A. 
               A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. 
               Ann Neurol. 
               1993; 
               34 
               410-412 
               
- 18 
               Campos Y, Martin M A, Rubio J C. et al .
               Leigh syndrome associated with the T9176C mutation in the ATPase 6 gene of mitochondrial
               DNA. 
               Neurology. 
               1997; 
               49 
               595-597 
               
- 19 
               Tatuch Y, Christodoulou J, Feigenbaum A. et al .
               Heteroplasmic mtDNA mutation (T → G) at 8993 can cause Leigh disease when the percentage
               of abnormal mtDNA is high. 
               Am J Hum Genet. 
               1992; 
               50 
               852-858 
               
- 20 
               Santorelli F M, Mak S C, Vazquez-Memije E. et al .
               Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation. 
               Pediatr Res. 
               1996; 
               39 
               914-917 
               
- 21 
               Tulinius M H, Houshmand M, Larsson N G. et al .
               De novo mutation in the mitochondrial ATP synthase subunit 6 gene (T8993G) with rapid
               segregation resulting in Leigh syndrome in the offspring. 
               Hum Genet. 
               1995; 
               96 
               290-294 
               
- 22 
               Garcia J J, Ogilvie I, Robinson B H, Capaldi R A. 
               Structure, functioning, and assembly of the ATP synthase in cells from patients with
               the T8993G mitochondrial DNA mutation. Comparison with the enzyme in Rho(0) cells
               completely lacking mtdna. 
               J Biol Chem. 
               2000; 
               275 
               11075-11081 
               
- 23 
               Ogilvie I, Capaldi R A. 
               Mutation of the mitochrondrially encoded ATPase 6 gene modeled in the ATP synthase
               of Escherichia coli. 
               FEBS Lett. 
               1999; 
               453 
               179-182 
               
- 24 
               Hartzog P E, Cain B D. 
               The aleu207 → arg mutation in F1F0-ATP synthase from Escherichia coli. A model for
               human mitochondrial disease. 
               J Biol Chem. 
               1993; 
               268 
               12250-12252 
               
- 25 
               Hartzog P E, Gardner J L, Cain B D. 
               Modelling the Leigh syndrome nt8993 T → C mutation in Escherichia coli F1F0 ATP synthase. 
               Int J Biochem Cell Biol. 
               1999; 
               31 
               769-776 
               
A.-R. Moslemi
            Department of Pathology, Sahlgrensa University Hospital
            
            41345 Göteborg
            
            Sweden
            
            Email: ali-reza.moslemi@pathology.gu.se